Código QR (código de barras bidimensional)

P180 | ACCELERATED INFUSION OF ISATUXIMAB: SINGLE-CENTER REAL-WORLD EVIDENCE SUPPORTING A 30-MINUTE ADMINISTRATION.

Background: Isatuximab (Isa) is an anti-CD38 monoclonal antibody currently approved for relapsed/refractory multiple myeloma (RRMM), in combination with either carfilzomib-dexamethasone (Isa-Kd) after 1 prior line of therapy (LOT) or pomalidomide-dexamethasone (Isa-Pd) after 2 prior LOTs. Infusion-r...

תיאור מלא

שמור ב:
Principais autores: R. Restuccia, K. Mancuso, M. Talarico, M. Puppi, E. Manzato, I. Sacchetti, S. Masci, S. Ghibellini, M. Iezza, P. Tacchetti, L. Pantani, S. Barbato, I. Rizzello, E. Zamagni
פורמט: Artigo
שפה:Inglês
יצא לאור: Ferrata Storti Foundation 2025-09-01
סדרה:Haematologica
גישה מקוונת:https://haematologica.org/article/view/12377
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים